Last reviewed · How we verify

NCT03789526

Ultrasound-guided Intervention and Hand Tenosynovitis in Patients With Diabetes Mellitus

Completed NA Last updated 11 June 2019
What this trial tests

NA trial testing ultrasound guidance in Ultrasound Guided Injection in 52 participants. Completed in 1 February 2019.

Timeline
11 December 2018
Primary endpoint
31 January 2019
1 February 2019

Quick facts

Lead sponsorAl-Azhar University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment52
Start date11 December 2018
Primary completion31 January 2019
Estimated completion1 February 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Al-Azhar University

Who can join

Eligibility, any sex, with Ultrasound Guided Injection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Evaluates the efficacy of ultrasound guided versus clinically guided steroid injection in the management of tenosynovitis in DM patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ultrasound guidance

Trials testing the same drug.

Other recruiting trials for Ultrasound Guided Injection

Currently open trials in the same condition.

Other Al-Azhar University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03789526.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing